When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.